The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer
Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.
Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.
A new study on prescription opioid use in the United States finds that while dosages and amounts are dropping, longer-term prescriptions and prescriptions lasting longer than 30 days are rising. And Americans continue dying.
Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer.
Apyx Medical shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of J-Plasma/Renuvion for use in dermal resurfacing procedures.
Health care costs in the United States are generally measured as the highest in the world. Last year, many Americans could not afford their health care costs.
Tricida shares jumped on Thursday after the firm announced results from its chronic kidney disease study.
Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with chronic kidney disease.
According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.
This is one of those mergers that is not getting the warm fuzzy feeling that management teams love to see.
Axsome shares jumped on Wednesday after the firm gave an update from the FDA regarding its AXS-05 for the treatment of major depressive disorder.
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Tuesday afternoon, the attorney general of Oklahoma is expected to announce that the state has reached a settlement with Purdue Pharma that will see the state receive a $275 million payout from the company.
The U.S. FDA has proposed new guidelines to address cybersecurity threats to implanted medical devices. Comments on the guidelines are split along lines of healthcare providers and medical device makers.
Curis shares jumped when the firm announced that it entered into an agreement to sell rights to a portion of royalty revenues on worldwide net sales of Erivedge.